These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 19812222

  • 1. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention.
    Ho E, Clarke JD, Dashwood RH.
    J Nutr; 2009 Dec; 139(12):2393-6. PubMed ID: 19812222
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.
    Myzak MC, Karplus PA, Chung FL, Dashwood RH.
    Cancer Res; 2004 Aug 15; 64(16):5767-74. PubMed ID: 15313918
    [Abstract] [Full Text] [Related]

  • 4. Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition.
    Tortorella SM, Royce SG, Licciardi PV, Karagiannis TC.
    Antioxid Redox Signal; 2015 Jun 01; 22(16):1382-424. PubMed ID: 25364882
    [Abstract] [Full Text] [Related]

  • 5. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.
    Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E.
    Carcinogenesis; 2006 Apr 01; 27(4):811-9. PubMed ID: 16280330
    [Abstract] [Full Text] [Related]

  • 6. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly.
    Rajendran P, Delage B, Dashwood WM, Yu TW, Wuth B, Williams DE, Ho E, Dashwood RH.
    Mol Cancer; 2011 May 30; 10():68. PubMed ID: 21624135
    [Abstract] [Full Text] [Related]

  • 7. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
    Abbas A, Hall JA, Patterson WL, Ho E, Hsu A, Al-Mulla F, Georgel PT.
    Biochem Cell Biol; 2016 Feb 30; 94(1):71-81. PubMed ID: 26458818
    [Abstract] [Full Text] [Related]

  • 8. Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds.
    Nian H, Delage B, Ho E, Dashwood RH.
    Environ Mol Mutagen; 2009 Apr 30; 50(3):213-21. PubMed ID: 19197985
    [Abstract] [Full Text] [Related]

  • 9. Dietary histone deacetylase inhibitors: from cells to mice to man.
    Dashwood RH, Ho E.
    Semin Cancer Biol; 2007 Oct 30; 17(5):363-9. PubMed ID: 17555985
    [Abstract] [Full Text] [Related]

  • 10. The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.
    Abbaoui B, Telu KH, Lucas CR, Thomas-Ahner JM, Schwartz SJ, Clinton SK, Freitas MA, Mortazavi A.
    J Proteomics; 2017 Mar 06; 156():94-103. PubMed ID: 28132875
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane.
    Myzak MC, Dashwood RH.
    Curr Drug Targets; 2006 Apr 06; 7(4):443-52. PubMed ID: 16611031
    [Abstract] [Full Text] [Related]

  • 12. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
    Paul B, Li Y, Tollefsbol TO.
    Int J Mol Sci; 2018 Jun 13; 19(6):. PubMed ID: 29899271
    [Abstract] [Full Text] [Related]

  • 13. Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial.
    Zhang Z, Garzotto M, Davis EW, Mori M, Stoller WA, Farris PE, Wong CP, Beaver LM, Thomas GV, Williams DE, Dashwood RH, Hendrix DA, Ho E, Shannon J.
    Nutr Cancer; 2020 Jun 13; 72(1):74-87. PubMed ID: 31155953
    [Abstract] [Full Text] [Related]

  • 14. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice.
    Myzak MC, Dashwood WM, Orner GA, Ho E, Dashwood RH.
    FASEB J; 2006 Mar 13; 20(3):506-8. PubMed ID: 16407454
    [Abstract] [Full Text] [Related]

  • 15. Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6.
    Gibbs A, Schwartzman J, Deng V, Alumkal J.
    Proc Natl Acad Sci U S A; 2009 Sep 29; 106(39):16663-8. PubMed ID: 19805354
    [Abstract] [Full Text] [Related]

  • 16. The effect of sulforaphane on histone deacetylase activity in keratinocytes: Differences between in vitro and in vivo analyses.
    Dickinson SE, Rusche JJ, Bec SL, Horn DJ, Janda J, Rim SH, Smith CL, Bowden GT.
    Mol Carcinog; 2015 Nov 29; 54(11):1513-20. PubMed ID: 25307283
    [Abstract] [Full Text] [Related]

  • 17. Off-target effects of sulforaphane include the derepression of long terminal repeats through histone acetylation events.
    Baier SR, Zbasnik R, Schlegel V, Zempleni J.
    J Nutr Biochem; 2014 Jun 29; 25(6):665-8. PubMed ID: 24746830
    [Abstract] [Full Text] [Related]

  • 18. Multi-targeted prevention of cancer by sulforaphane.
    Clarke JD, Dashwood RH, Ho E.
    Cancer Lett; 2008 Oct 08; 269(2):291-304. PubMed ID: 18504070
    [Abstract] [Full Text] [Related]

  • 19. HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates.
    Rajendran P, Kidane AI, Yu TW, Dashwood WM, Bisson WH, Löhr CV, Ho E, Williams DE, Dashwood RH.
    Epigenetics; 2013 Jun 08; 8(6):612-23. PubMed ID: 23770684
    [Abstract] [Full Text] [Related]

  • 20. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects.
    Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E.
    Exp Biol Med (Maywood); 2007 Feb 08; 232(2):227-34. PubMed ID: 17259330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.